David M. Goldstein
Director Técnico/Científico/I+D en PRINCIPIA BIOPHARMA INC. .
Cargos activos de David M. Goldstein
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| PRINCIPIA BIOPHARMA INC. | Director Técnico/Científico/I+D | 01/01/2016 | - |
Frontier Medicines Corp.
 Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA. | Director/Miembro de la Junta | 30/03/2021 | - |
Historial de carrera de David M. Goldstein
Antiguos cargos conocidos de David M. Goldstein.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ROCHE HOLDING AG | Corporate Officer/Principal | 01/01/1994 | 01/01/2011 |
| Stanford University | Corporate Officer/Principal | - | - |
Formación de David M. Goldstein.
| Franklin & Marshall College | Undergraduate Degree |
| University of Virginia | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 7 |
Operativa
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ROCHE HOLDING AG | Health Technology |
| Empresas privadas | 2 |
|---|---|
Principia Biopharma, Inc.
 Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Principia Biopharma, Inc. is a biopharmaceutical company, which engages in designing and developing oral therapies to patients with significant unmet medical needs in immunology and oncology. It operates through Tailored Covalency platform, which enables to develop small molecule inhibitors of enzymes and receptor ligands with potencies and selectivities that rival those of injectable biologics, yet maintain the convenience of a pill. Its product pipeline includes PRN1008, PRN2246, PRN1371, and immunoproteasome inhibitor. The company was founded by Jack Taunton and Richard A. Miller on October 6, 2008 and is headquartered in South San Francisco, CA. | Health Technology |
Frontier Medicines Corp.
Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA. | Health Technology |
- Bolsa de valores
- Insiders
- David M. Goldstein
- Experiencia
